Contact Information

Call us at: (614)722-4515

Center for Gene Therapy700 Children’s DriveColumbus, OH 43205 (map)

Learn more about Lindsay N Alfano

Biography

Lindsay Alfano, PT, DPT, PCS, a physical therapist and researcher specializing in the care and evaluation of patients with neuromuscular disorders, is a principal investigator in the Center for Gene Therapy and a research assistant professor of Pediatrics at The Ohio State University. Dr. Alfano serves an integral role in planning and designing clinical trials and contributes to protocol development, outcome measure selection, statistical analysis, and interpretation for ongoing clinical trials within the Center for Gene Therapy and throughout the wider research community. Dr. Alfano serves on an international consortium of neuromuscular physical therapy experts that provide industry-standard training and reliability for multisite international trials. Her research goals focus on standardizing training in rare disease, as well as developing and promoting optimal assessment tools to measure change in movement abilities while minimizing the burden of testing. She has co-developed novel outcomes including the ACTIVE WSV & ACTIVE-mini systems, 100-meter timed test, and the Neuromuscular Gross Motor Outcome (GRO). In response to the COVID-19 pandemic, Dr. Alfano and the neuromuscular physical therapy team at Nationwide Children’s Hospital have led initiatives to understand and validate remote testing for patients with neuromuscular diseases for clinical and research purposes.

Academic and Clinical Areas

Physical Therapy

Developmental Physical Therapy Team

Center for Gene Therapy

Principal Investigator

Primary Department

Center for Gene Therapy

Awards, Honors & Organizations

Outstanding Team of the Year, Research Institute, 2020 Excellence in Innovation Award, Research Institute, 2019 Outstanding Poster Award, World Muscle Society, 2012 Pediatric Clinical Specialist, American Physical Therapy Association, 2010 Employee of the Quarter, Nationwide Children’s Hospital, 2010 Memorial Fund Scholarship, American Physical Therapy Association, 2010 Golden Goniometer, Nationwide Children’s Hospital, 2009 Executive Board, TREAT-NMD, 2021 - Present Present Executive Board, Muscle Study Group, 2015 - 2019

Research

Lab(s)

Center for Gene Therapy

Publications

                  Miller NF, Alfano LN, Iammarino MA, Connolly AM, Moore-Clingenpeel M, Powers BR, Tsao CY, Waldrop MA, Flanigan KM, Mendell JR, Lowes LP. Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional Tests. Pediatr Neurol. 2020 Dec; 113: 15-20.

                


                  Alfano LN, Miller NF, Iammarino MA, Moore Clingenpeel M, Lowes SL, Dugan ME, Kissel JT, Al Zaidy S, Tsao CY, Lowes LP. ACTIVE (Ability Captured Through Interactive Video Evaluation) workspace volume video game to quantify meaningful change in spinal muscular atrophy. Dev Med Child Neurol. 2020 Mar; 62: 303-309.

                


                  Alfano LN, Miller NF, Berry KM, Yin H, Rolf KE, Flanigan KM, Mendell JR, Lowes LP. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials. Neuromuscul Disord. 2017 May; 27: 452-457.

                


                  Alfano LN, Yin H, Dvorchik I, Maus EG, Flanigan KM, Mendell JR, Lowes LP. Modeling functional decline over time in sporadic inclusion body myositis. Muscle Nerve. 2017 Apr; 55: 526-531.

View More Publications

Contact Information

Center for Gene Therapy

Call us at: (614)722-4515

                    700 Children's DriveColumbus, OH 43205 (map)

Contact Information

Call us at: (614)722-4515

Center for Gene Therapy700 Children’s DriveColumbus, OH 43205 (map)

Learn more about Lindsay N Alfano

Biography

Lindsay Alfano, PT, DPT, PCS, a physical therapist and researcher specializing in the care and evaluation of patients with neuromuscular disorders, is a principal investigator in the Center for Gene Therapy and a research assistant professor of Pediatrics at The Ohio State University. Dr. Alfano serves an integral role in planning and designing clinical trials and contributes to protocol development, outcome measure selection, statistical analysis, and interpretation for ongoing clinical trials within the Center for Gene Therapy and throughout the wider research community. Dr. Alfano serves on an international consortium of neuromuscular physical therapy experts that provide industry-standard training and reliability for multisite international trials. Her research goals focus on standardizing training in rare disease, as well as developing and promoting optimal assessment tools to measure change in movement abilities while minimizing the burden of testing. She has co-developed novel outcomes including the ACTIVE WSV & ACTIVE-mini systems, 100-meter timed test, and the Neuromuscular Gross Motor Outcome (GRO). In response to the COVID-19 pandemic, Dr. Alfano and the neuromuscular physical therapy team at Nationwide Children’s Hospital have led initiatives to understand and validate remote testing for patients with neuromuscular diseases for clinical and research purposes.

Academic and Clinical Areas

Physical Therapy

Developmental Physical Therapy Team

Center for Gene Therapy

Principal Investigator

Primary Department

Center for Gene Therapy

Awards, Honors & Organizations

Outstanding Team of the Year, Research Institute, 2020 Excellence in Innovation Award, Research Institute, 2019 Outstanding Poster Award, World Muscle Society, 2012 Pediatric Clinical Specialist, American Physical Therapy Association, 2010 Employee of the Quarter, Nationwide Children’s Hospital, 2010 Memorial Fund Scholarship, American Physical Therapy Association, 2010 Golden Goniometer, Nationwide Children’s Hospital, 2009 Executive Board, TREAT-NMD, 2021 - Present Present Executive Board, Muscle Study Group, 2015 - 2019

Research

Lab(s)

Center for Gene Therapy

Publications

                  Miller NF, Alfano LN, Iammarino MA, Connolly AM, Moore-Clingenpeel M, Powers BR, Tsao CY, Waldrop MA, Flanigan KM, Mendell JR, Lowes LP. Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional Tests. Pediatr Neurol. 2020 Dec; 113: 15-20.

                


                  Alfano LN, Miller NF, Iammarino MA, Moore Clingenpeel M, Lowes SL, Dugan ME, Kissel JT, Al Zaidy S, Tsao CY, Lowes LP. ACTIVE (Ability Captured Through Interactive Video Evaluation) workspace volume video game to quantify meaningful change in spinal muscular atrophy. Dev Med Child Neurol. 2020 Mar; 62: 303-309.

                


                  Alfano LN, Miller NF, Berry KM, Yin H, Rolf KE, Flanigan KM, Mendell JR, Lowes LP. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials. Neuromuscul Disord. 2017 May; 27: 452-457.

                


                  Alfano LN, Yin H, Dvorchik I, Maus EG, Flanigan KM, Mendell JR, Lowes LP. Modeling functional decline over time in sporadic inclusion body myositis. Muscle Nerve. 2017 Apr; 55: 526-531.

View More Publications

Contact Information

Center for Gene Therapy

Call us at: (614)722-4515

                    700 Children's DriveColumbus, OH 43205 (map)

Contact Information

Call us at: (614)722-4515

Center for Gene Therapy700 Children’s DriveColumbus, OH 43205 (map)

Learn more about Lindsay N Alfano

Contact Information

  • Call us at:
  • (614)722-4515
  • Center for Gene Therapy700 Children’s DriveColumbus, OH 43205 (map)

Learn more about Lindsay N Alfano

Biography

Lindsay Alfano, PT, DPT, PCS, a physical therapist and researcher specializing in the care and evaluation of patients with neuromuscular disorders, is a principal investigator in the Center for Gene Therapy and a research assistant professor of Pediatrics at The Ohio State University. Dr. Alfano serves an integral role in planning and designing clinical trials and contributes to protocol development, outcome measure selection, statistical analysis, and interpretation for ongoing clinical trials within the Center for Gene Therapy and throughout the wider research community. Dr. Alfano serves on an international consortium of neuromuscular physical therapy experts that provide industry-standard training and reliability for multisite international trials. Her research goals focus on standardizing training in rare disease, as well as developing and promoting optimal assessment tools to measure change in movement abilities while minimizing the burden of testing. She has co-developed novel outcomes including the ACTIVE WSV & ACTIVE-mini systems, 100-meter timed test, and the Neuromuscular Gross Motor Outcome (GRO). In response to the COVID-19 pandemic, Dr. Alfano and the neuromuscular physical therapy team at Nationwide Children’s Hospital have led initiatives to understand and validate remote testing for patients with neuromuscular diseases for clinical and research purposes.

Biography

Lindsay Alfano, PT, DPT, PCS, a physical therapist and researcher specializing in the care and evaluation of patients with neuromuscular disorders, is a principal investigator in the Center for Gene Therapy and a research assistant professor of Pediatrics at The Ohio State University. Dr. Alfano serves an integral role in planning and designing clinical trials and contributes to protocol development, outcome measure selection, statistical analysis, and interpretation for ongoing clinical trials within the Center for Gene Therapy and throughout the wider research community. Dr. Alfano serves on an international consortium of neuromuscular physical therapy experts that provide industry-standard training and reliability for multisite international trials. Her research goals focus on standardizing training in rare disease, as well as developing and promoting optimal assessment tools to measure change in movement abilities while minimizing the burden of testing. She has co-developed novel outcomes including the ACTIVE WSV & ACTIVE-mini systems, 100-meter timed test, and the Neuromuscular Gross Motor Outcome (GRO). In response to the COVID-19 pandemic, Dr. Alfano and the neuromuscular physical therapy team at Nationwide Children’s Hospital have led initiatives to understand and validate remote testing for patients with neuromuscular diseases for clinical and research purposes.

Biography

Lindsay Alfano, PT, DPT, PCS, a physical therapist and researcher specializing in the care and evaluation of patients with neuromuscular disorders, is a principal investigator in the Center for Gene Therapy and a research assistant professor of Pediatrics at The Ohio State University. Dr. Alfano serves an integral role in planning and designing clinical trials and contributes to protocol development, outcome measure selection, statistical analysis, and interpretation for ongoing clinical trials within the Center for Gene Therapy and throughout the wider research community. Dr. Alfano serves on an international consortium of neuromuscular physical therapy experts that provide industry-standard training and reliability for multisite international trials. Her research goals focus on standardizing training in rare disease, as well as developing and promoting optimal assessment tools to measure change in movement abilities while minimizing the burden of testing. She has co-developed novel outcomes including the ACTIVE WSV & ACTIVE-mini systems, 100-meter timed test, and the Neuromuscular Gross Motor Outcome (GRO). In response to the COVID-19 pandemic, Dr. Alfano and the neuromuscular physical therapy team at Nationwide Children’s Hospital have led initiatives to understand and validate remote testing for patients with neuromuscular diseases for clinical and research purposes.

Lindsay Alfano, PT, DPT, PCS, a physical therapist and researcher specializing in the care and evaluation of patients with neuromuscular disorders, is a principal investigator in the Center for Gene Therapy and a research assistant professor of Pediatrics at The Ohio State University. Dr. Alfano serves an integral role in planning and designing clinical trials and contributes to protocol development, outcome measure selection, statistical analysis, and interpretation for ongoing clinical trials within the Center for Gene Therapy and throughout the wider research community. Dr. Alfano serves on an international consortium of neuromuscular physical therapy experts that provide industry-standard training and reliability for multisite international trials. Her research goals focus on standardizing training in rare disease, as well as developing and promoting optimal assessment tools to measure change in movement abilities while minimizing the burden of testing. She has co-developed novel outcomes including the ACTIVE WSV & ACTIVE-mini systems, 100-meter timed test, and the Neuromuscular Gross Motor Outcome (GRO). In response to the COVID-19 pandemic, Dr. Alfano and the neuromuscular physical therapy team at Nationwide Children’s Hospital have led initiatives to understand and validate remote testing for patients with neuromuscular diseases for clinical and research purposes.

Lindsay Alfano, PT, DPT, PCS, a physical therapist and researcher specializing in the care and evaluation of patients with neuromuscular disorders, is a principal investigator in the Center for Gene Therapy and a research assistant professor of Pediatrics at The Ohio State University.

Dr. Alfano serves an integral role in planning and designing clinical trials and contributes to protocol development, outcome measure selection, statistical analysis, and interpretation for ongoing clinical trials within the Center for Gene Therapy and throughout the wider research community. Dr. Alfano serves on an international consortium of neuromuscular physical therapy experts that provide industry-standard training and reliability for multisite international trials. Her research goals focus on standardizing training in rare disease, as well as developing and promoting optimal assessment tools to measure change in movement abilities while minimizing the burden of testing. She has co-developed novel outcomes including the ACTIVE WSV & ACTIVE-mini systems, 100-meter timed test, and the Neuromuscular Gross Motor Outcome (GRO). In response to the COVID-19 pandemic, Dr. Alfano and the neuromuscular physical therapy team at Nationwide Children’s Hospital have led initiatives to understand and validate remote testing for patients with neuromuscular diseases for clinical and research purposes.

Academic and Clinical Areas

Physical Therapy

Developmental Physical Therapy Team

Center for Gene Therapy

Principal Investigator

Primary Department

Center for Gene Therapy

Academic and Clinical Areas

Physical Therapy

Developmental Physical Therapy Team

Center for Gene Therapy

Principal Investigator

Primary Department

Center for Gene Therapy

Academic and Clinical Areas

Physical Therapy

Developmental Physical Therapy Team

Center for Gene Therapy

Principal Investigator

Primary Department

Center for Gene Therapy

Physical Therapy

Developmental Physical Therapy Team

Center for Gene Therapy

Principal Investigator

Primary Department

Center for Gene Therapy

  • Physical Therapy
  • Developmental Physical Therapy Team
  • Center for Gene Therapy
  • Principal Investigator
  • Primary Department
  • Center for Gene Therapy

Awards, Honors & Organizations

Outstanding Team of the Year, Research Institute, 2020 Excellence in Innovation Award, Research Institute, 2019 Outstanding Poster Award, World Muscle Society, 2012 Pediatric Clinical Specialist, American Physical Therapy Association, 2010 Employee of the Quarter, Nationwide Children’s Hospital, 2010 Memorial Fund Scholarship, American Physical Therapy Association, 2010 Golden Goniometer, Nationwide Children’s Hospital, 2009 Executive Board, TREAT-NMD, 2021 - Present Present Executive Board, Muscle Study Group, 2015 - 2019

Awards, Honors & Organizations

Outstanding Team of the Year, Research Institute, 2020 Excellence in Innovation Award, Research Institute, 2019 Outstanding Poster Award, World Muscle Society, 2012 Pediatric Clinical Specialist, American Physical Therapy Association, 2010 Employee of the Quarter, Nationwide Children’s Hospital, 2010 Memorial Fund Scholarship, American Physical Therapy Association, 2010 Golden Goniometer, Nationwide Children’s Hospital, 2009 Executive Board, TREAT-NMD, 2021 - Present Present Executive Board, Muscle Study Group, 2015 - 2019

Awards, Honors & Organizations

Outstanding Team of the Year, Research Institute, 2020 Excellence in Innovation Award, Research Institute, 2019 Outstanding Poster Award, World Muscle Society, 2012 Pediatric Clinical Specialist, American Physical Therapy Association, 2010 Employee of the Quarter, Nationwide Children’s Hospital, 2010 Memorial Fund Scholarship, American Physical Therapy Association, 2010 Golden Goniometer, Nationwide Children’s Hospital, 2009 Executive Board, TREAT-NMD, 2021 - Present Present Executive Board, Muscle Study Group, 2015 - 2019

Outstanding Team of the Year, Research Institute, 2020 Excellence in Innovation Award, Research Institute, 2019 Outstanding Poster Award, World Muscle Society, 2012 Pediatric Clinical Specialist, American Physical Therapy Association, 2010 Employee of the Quarter, Nationwide Children’s Hospital, 2010 Memorial Fund Scholarship, American Physical Therapy Association, 2010 Golden Goniometer, Nationwide Children’s Hospital, 2009 Executive Board, TREAT-NMD, 2021 - Present Present Executive Board, Muscle Study Group, 2015 - 2019

  • Outstanding Team of the Year, Research Institute, 2020
  • Excellence in Innovation Award, Research Institute, 2019
  • Outstanding Poster Award, World Muscle Society, 2012
  • Pediatric Clinical Specialist, American Physical Therapy Association, 2010
  • Employee of the Quarter, Nationwide Children’s Hospital, 2010
  • Memorial Fund Scholarship, American Physical Therapy Association, 2010
  • Golden Goniometer, Nationwide Children’s Hospital, 2009
  • Executive Board, TREAT-NMD, 2021 - Present
  • Present Executive Board, Muscle Study Group, 2015 - 2019

Research

Lab(s)

Center for Gene Therapy

Publications

                  Miller NF, Alfano LN, Iammarino MA, Connolly AM, Moore-Clingenpeel M, Powers BR, Tsao CY, Waldrop MA, Flanigan KM, Mendell JR, Lowes LP. Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional Tests. Pediatr Neurol. 2020 Dec; 113: 15-20.

                


                  Alfano LN, Miller NF, Iammarino MA, Moore Clingenpeel M, Lowes SL, Dugan ME, Kissel JT, Al Zaidy S, Tsao CY, Lowes LP. ACTIVE (Ability Captured Through Interactive Video Evaluation) workspace volume video game to quantify meaningful change in spinal muscular atrophy. Dev Med Child Neurol. 2020 Mar; 62: 303-309.

                


                  Alfano LN, Miller NF, Berry KM, Yin H, Rolf KE, Flanigan KM, Mendell JR, Lowes LP. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials. Neuromuscul Disord. 2017 May; 27: 452-457.

                


                  Alfano LN, Yin H, Dvorchik I, Maus EG, Flanigan KM, Mendell JR, Lowes LP. Modeling functional decline over time in sporadic inclusion body myositis. Muscle Nerve. 2017 Apr; 55: 526-531.

View More Publications

Research

Lab(s)

Center for Gene Therapy

Publications

                  Miller NF, Alfano LN, Iammarino MA, Connolly AM, Moore-Clingenpeel M, Powers BR, Tsao CY, Waldrop MA, Flanigan KM, Mendell JR, Lowes LP. Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional Tests. Pediatr Neurol. 2020 Dec; 113: 15-20.

                


                  Alfano LN, Miller NF, Iammarino MA, Moore Clingenpeel M, Lowes SL, Dugan ME, Kissel JT, Al Zaidy S, Tsao CY, Lowes LP. ACTIVE (Ability Captured Through Interactive Video Evaluation) workspace volume video game to quantify meaningful change in spinal muscular atrophy. Dev Med Child Neurol. 2020 Mar; 62: 303-309.

                


                  Alfano LN, Miller NF, Berry KM, Yin H, Rolf KE, Flanigan KM, Mendell JR, Lowes LP. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials. Neuromuscul Disord. 2017 May; 27: 452-457.

                


                  Alfano LN, Yin H, Dvorchik I, Maus EG, Flanigan KM, Mendell JR, Lowes LP. Modeling functional decline over time in sporadic inclusion body myositis. Muscle Nerve. 2017 Apr; 55: 526-531.

View More Publications

Research

Lab(s)

Center for Gene Therapy

Publications

                  Miller NF, Alfano LN, Iammarino MA, Connolly AM, Moore-Clingenpeel M, Powers BR, Tsao CY, Waldrop MA, Flanigan KM, Mendell JR, Lowes LP. Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional Tests. Pediatr Neurol. 2020 Dec; 113: 15-20.

                


                  Alfano LN, Miller NF, Iammarino MA, Moore Clingenpeel M, Lowes SL, Dugan ME, Kissel JT, Al Zaidy S, Tsao CY, Lowes LP. ACTIVE (Ability Captured Through Interactive Video Evaluation) workspace volume video game to quantify meaningful change in spinal muscular atrophy. Dev Med Child Neurol. 2020 Mar; 62: 303-309.

                


                  Alfano LN, Miller NF, Berry KM, Yin H, Rolf KE, Flanigan KM, Mendell JR, Lowes LP. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials. Neuromuscul Disord. 2017 May; 27: 452-457.

                


                  Alfano LN, Yin H, Dvorchik I, Maus EG, Flanigan KM, Mendell JR, Lowes LP. Modeling functional decline over time in sporadic inclusion body myositis. Muscle Nerve. 2017 Apr; 55: 526-531.

View More Publications

Lab(s)

Center for Gene Therapy

Publications

                  Miller NF, Alfano LN, Iammarino MA, Connolly AM, Moore-Clingenpeel M, Powers BR, Tsao CY, Waldrop MA, Flanigan KM, Mendell JR, Lowes LP. Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional Tests. Pediatr Neurol. 2020 Dec; 113: 15-20.

                


                  Alfano LN, Miller NF, Iammarino MA, Moore Clingenpeel M, Lowes SL, Dugan ME, Kissel JT, Al Zaidy S, Tsao CY, Lowes LP. ACTIVE (Ability Captured Through Interactive Video Evaluation) workspace volume video game to quantify meaningful change in spinal muscular atrophy. Dev Med Child Neurol. 2020 Mar; 62: 303-309.

                


                  Alfano LN, Miller NF, Berry KM, Yin H, Rolf KE, Flanigan KM, Mendell JR, Lowes LP. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials. Neuromuscul Disord. 2017 May; 27: 452-457.

                


                  Alfano LN, Yin H, Dvorchik I, Maus EG, Flanigan KM, Mendell JR, Lowes LP. Modeling functional decline over time in sporadic inclusion body myositis. Muscle Nerve. 2017 Apr; 55: 526-531.

View More Publications

Lab(s)

Center for Gene Therapy

                  Miller NF, Alfano LN, Iammarino MA, Connolly AM, Moore-Clingenpeel M, Powers BR, Tsao CY, Waldrop MA, Flanigan KM, Mendell JR, Lowes LP. Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional Tests. Pediatr Neurol. 2020 Dec; 113: 15-20.

                


                  Alfano LN, Miller NF, Iammarino MA, Moore Clingenpeel M, Lowes SL, Dugan ME, Kissel JT, Al Zaidy S, Tsao CY, Lowes LP. ACTIVE (Ability Captured Through Interactive Video Evaluation) workspace volume video game to quantify meaningful change in spinal muscular atrophy. Dev Med Child Neurol. 2020 Mar; 62: 303-309.

                


                  Alfano LN, Miller NF, Berry KM, Yin H, Rolf KE, Flanigan KM, Mendell JR, Lowes LP. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials. Neuromuscul Disord. 2017 May; 27: 452-457.

                


                  Alfano LN, Yin H, Dvorchik I, Maus EG, Flanigan KM, Mendell JR, Lowes LP. Modeling functional decline over time in sporadic inclusion body myositis. Muscle Nerve. 2017 Apr; 55: 526-531.

View More Publications

Lab(s)

Center for Gene Therapy

  • Center for Gene Therapy

  • Miller NF, Alfano LN, Iammarino MA, Connolly AM, Moore-Clingenpeel M, Powers BR, Tsao CY, Waldrop MA, Flanigan KM, Mendell JR, Lowes LP. Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional Tests. Pediatr Neurol. 2020 Dec; 113: 15-20.

  • Alfano LN, Miller NF, Iammarino MA, Moore Clingenpeel M, Lowes SL, Dugan ME, Kissel JT, Al Zaidy S, Tsao CY, Lowes LP. ACTIVE (Ability Captured Through Interactive Video Evaluation) workspace volume video game to quantify meaningful change in spinal muscular atrophy. Dev Med Child Neurol. 2020 Mar; 62: 303-309.

  • Alfano LN, Miller NF, Berry KM, Yin H, Rolf KE, Flanigan KM, Mendell JR, Lowes LP. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials. Neuromuscul Disord. 2017 May; 27: 452-457.

  • Alfano LN, Yin H, Dvorchik I, Maus EG, Flanigan KM, Mendell JR, Lowes LP. Modeling functional decline over time in sporadic inclusion body myositis. Muscle Nerve. 2017 Apr; 55: 526-531.

Contact Information

Center for Gene Therapy

Call us at: (614)722-4515

                    700 Children's DriveColumbus, OH 43205 (map)

Contact Information

Center for Gene Therapy

Call us at: (614)722-4515

                    700 Children's DriveColumbus, OH 43205 (map)

Contact Information

Center for Gene Therapy

Call us at: (614)722-4515

                    700 Children's DriveColumbus, OH 43205 (map)

Center for Gene Therapy

Call us at: (614)722-4515

                    700 Children's DriveColumbus, OH 43205 (map)

Call us at: (614)722-4515

                    700 Children's DriveColumbus, OH 43205 (map)

Call us at: (614)722-4515

                    700 Children's DriveColumbus, OH 43205 (map)
  • Call us at:
  • (614)722-4515
  • 700 Children’s DriveColumbus, OH 43205 (map)